Y. Hung

发表

Neutrophil Ratio of White Blood Cells as a Prognostic Predictor of Clostridioides difficile Infection

P. Tsai, W. Ko, Ching-Chi Lee, 2022, Journal of inflammation research.

Multicenter evaluation of two chemiluminescence and three lateral flow immunoassays for the diagnosis of COVID-19 and assessment of antibody dynamic responses to SARS-CoV-2 in Taiwan

Shyr-Chyr Chen, Chun-Eng Liu, W. Ko, 2020, Emerging microbes & infections.

Clostridioides difficile infection: an emerging zoonosis?

W. Ko, P. Hsueh, Ling-Shan Syue, 2021, Expert review of anti-infective therapy.

Prognostic Effects of Inappropriate Empirical Antimicrobial Therapy in Adults With Community-Onset Bacteremia: Age Matters

W. Ko, Po-Lin Chen, Ching-Chi Lee, 2022, Frontiers in Medicine.

Clinical Impact and Risk Factors of Nonsusceptibility to Third-Generation Cephalosporins Among Hospitalized Adults with Monomicrobial Enterobacteriaceae Bacteremia in Southern Taiwan: A Multicenter Study

W. Ko, Yeou-Lih Huang, Ching-Chi Lee, 2021, Infection and drug resistance.

Bloodstream infections in hospitalized adults with dengue fever: Clinical characteristics and recommended empirical therapy.

W. Ko, Hung-Jen Tang, Ching-Chuan Liu, 2019, Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi.

Clinical Impact of Sequence Type 131 in Adults with Community-Onset Monomicrobial Escherichia Coli Bacteremia

W. Ko, Hung-Jen Tang, N. Lee, 2018, Journal of clinical medicine.

W. Ko, Ching-Chi Lee, Chia-Ming Chang, 2017, Antimicrobial Agents and Chemotherapy.

Prognostic Effects of Delayed Administration of Appropriate Antimicrobials in Bacteraemic Adults Initially Presenting with Various Body Temperatures

W. Ko, Po-Lin Chen, Ching-Chi Lee, 2022, Infection and drug resistance.

A multicenter, randomized, open-label, controlled trial to evaluate the efficacy and tolerability of hydroxychloroquine and a retrospective study in adult patients with mild to moderate coronavirus disease 2019 (COVID-19)

C. Hsiao, W. Chung, Wei-Yao Wang, 2020, medRxiv.

Clinical Significance of Toxigenic Clostridioides difficile Growth in Stool Cultures during the Era of Nonculture Methods for the Diagnosis of C. difficile Infection

P. Tsai, W. Ko, Ching-Chi Lee, 2021, Microbiology spectrum.

Risk factors for Clostridium difficile-associated diarrhea among hospitalized adults with fecal toxigenic C. difficile colonization.

P. Tsai, W. Ko, Hsiu-Chuan Liu, 2015, Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi.

Cytomegalovirus disease in nonimmunocompromised, human immunodeficiency virus-negative adults with chronic kidney disease.

W. Ko, Chiung‐Yu Chen, N. Lee, 2014, Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi.

Risk Factors of Fecal Toxigenic or Non-Toxigenic Clostridium difficile Colonization: Impact of Toll-Like Receptor Polymorphisms and Prior Antibiotic Exposure

P. Tsai, W. Ko, Hsiu-Chuan Liu, 2013, PloS one.

Oral Nirmatrelvir/Ritonavir Therapy for COVID-19: The Dawn in the Dark?

P. Tsai, W. Ko, Ching-Chi Lee, 2022, Antibiotics.

Clostridioides difficile spores stimulate inflammatory cytokine responses and induce cytotoxicity in macrophages.

D. Paredes-Sabja, P. Tsai, Jenn-Wei Chen, 2021, Anaerobe.

Advances in the Application of Nanomaterials as Treatments for Bacterial Infectious Diseases

W. Ko, I. Huang, P. Tsai, 2021, Pharmaceutics.

The first case of severe Clostridium difficile ribotype 027 infection in Taiwan.

P. Tsai, W. Ko, Bo-Yang Tsai, 2015, The Journal of infection.

Clostridium difficile ribotype 126 in southern Taiwan: a cluster of three symptomatic cases.

P. Tsai, M. Wilcox, W. Ko, 2014, Anaerobe.

Effects of Inappropriate Administration of Empirical Antibiotics on Mortality in Adults With Bacteraemia: Systematic Review and Meta-Analysis

W. Ko, Ching-Chi Lee, Y. Hung, 2022, Frontiers in Medicine.

Comparisons of clinical characters in patients with pneumococcal and Legionella pneumonia.

W. Ko, N. Lee, Chiung-Zuei Chen, 2010, Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi.

W. Ko, Yeou-Lih Huang, Ching-Chi Lee, 2020, Infection and drug resistance.

Incidence of Aeromonas bacteremia in Southern Taiwan: vibrio and Salmonella bacteremia as comparators.

W. Ko, Hung-Jen Tang, Po-Lin Chen, 2014, Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi.

Community-onset Clostridium difficile infection at a tertiary medical center in southern Taiwan, 2007-2015.

W. Ko, N. Lee, Chia-Wen Li, 2016, Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi.

Impact of Toxigenic Clostridium difficile Colonization and Infection among Hospitalized Adults at a District Hospital in Southern Taiwan

P. Tsai, J. Wu, W. Ko, 2012, PloS one.

Zoonotic potential of the Clostridium difficile RT078 family in Taiwan.

P. Tsai, W. Ko, T. Chen, 2016, Anaerobe.

Severe Clostridium difficile infections in intensive care units: Diverse clinical presentations.

P. Tsai, W. Ko, Bo-Yang Tsai, 2020, Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi.

Nationwide surveillance of ribotypes and antimicrobial susceptibilities of toxigenic Clostridium difficile isolates with an emphasis on reduced doxycycline and tigecycline susceptibilities among ribotype 078 lineage isolates in Taiwan

P. Tsai, W. Ko, P. Hsueh, 2018, Infection and drug resistance.

Predominance of Clostridium difficile Ribotypes 017 and 078 among Toxigenic Clinical Isolates in Southern Taiwan

P. Tsai, W. Ko, I. Huang, 2016, PloS one.

The Potential of Probiotics to Eradicate Gut Carriage of Pathogenic or Antimicrobial-Resistant Enterobacterales

P. Tsai, W. Ko, P. Hsueh, 2021, Antibiotics.

Comparative genomic analysis of Clostridium difficile ribotype 027 strains including the newly sequenced strain NCKUH-21 isolated from a patient in Taiwan

M. Tomita, P. Tsai, Haruo Suzuki, 2017, Gut Pathogens.

The ATP-P2X7 Signaling Axis Is an Essential Sentinel for Intracellular Clostridium difficile Pathogen-Induced Inflammasome Activation

Y. Tsai, P. Tsai, W. Ko, 2018, Front. Cell. Infect. Microbiol..

Clinical impact of Clostridium difficile colonization.

P. Tsai, W. Ko, Jen-Chieh Lee, 2015, Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi.

Impacts of Corticosteroid Therapy at Acute Stage of Hospital-Onset Clostridioides difficile Infections

P. Tsai, W. Ko, Ching-Chi Lee, 2022, Infection and drug resistance.

Reappraisal of the clinical role of metronidazole therapy for Clostridioides difficile infection in Taiwan: A multicenter prospective study.

P. Tsai, W. Ko, P. Hsueh, 2022, Journal of the Formosan Medical Association = Taiwan yi zhi.

Lauric Acid Is an Inhibitor of Clostridium difficile Growth in Vitro and Reduces Inflammation in a Mouse Infection Model

D. Paredes-Sabja, P. Tsai, Jenn-Wei Chen, 2018, Front. Microbiol..

Clostridium difficile infection at a medical center in southern Taiwan: incidence, clinical features and prognosis.

W. Ko, Jing-Jou Yan, N. Lee, 2010, Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi.

De-isolation criterion of real-time PCR test in patients with COVID-19: Two or three consecutive negative nasopharyngeal swabs?

W. Ko, N. Lee, Chia-Wen Li, 2020, Journal of Microbiology, Immunology and Infection.

Proton-Pump Inhibitor Exposure Aggravates Clostridium difficile-Associated Colitis: Evidence From a Mouse Model.

P. Tsai, W. Ko, Yi-Hsuan Chen, 2015, The Journal of infectious diseases.

A brief on new waves of monkeypox and vaccines and antiviral drugs for monkeypox

W. Ko, P. Hsueh, Ching-Chi Lee, 2022, Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi.

Clinical benefits of antimicrobial de-escalation in adults with community-onset monomicrobial Escherichia coli, Klebsiella species and Proteus mirabilis bacteremia.

W. Ko, Ching-Chi Lee, Jiun-Ling Wang, 2017, International journal of antimicrobial agents.

COVID-19-associated candidiasis and the emerging concern of Candida auris infections

W. Ko, Chien-Hao Tseng, N. Lee, 2022, Journal of Microbiology, Immunology and Infection.

Doxycycline and Tigecycline: Two Friendly Drugs with a Low Association with Clostridium Difficile Infection

P. Tsai, W. Ko, Jen-Chieh Lee, 2015, Antibiotics.

Gut Dysbiosis during COVID-19 and Potential Effect of Probiotics

P. Tsai, W. Ko, Ching-Chi Lee, 2021, Microorganisms.

An outbreak of chryseobacterium indologenes bacteremia: Pseudobacteremia of unrecognized sources

W. Ko, Chun-Wei Chiu, Y. Hung, 2015 .

Association of Single Nucleotide Polymorphisms in Nucleotide-Binding Domain Leucine-Rich Repeat Protein 1 with Clostridioides difficile Colonization or Infection

P. Tsai, W. Ko, Bo-Yang Tsai, 2023, Infection and drug resistance.

Effects of PPARγ and RBP4 Gene Variants on Metabolic Syndrome in HIV-Infected Patients with Anti-Retroviral Therapy

Y. Tsai, P. Tsai, W. Ko, 2012, PloS one.

Tolerability of teicoplanin in 117 hospitalized adults with previous vancomycin-induced fever, rash, or neutropenia: a retrospective chart review.

W. Ko, N. Lee, Po-Lin Chen, 2009, Clinical therapeutics.

Risk factors and clinical impact of levofloxacin or cefazolin nonsusceptibility or ESBL production among uropathogens in adults with community-onset urinary tract infections.

W. Ko, Po-Lin Chen, Y. Hung, 2014, Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi.

The Role of Toll-Like Receptor-2 in Clostridioides difficile Infection: Evidence From a Mouse Model and Clinical Patients

P. Tsai, W. Ko, Chih-Yu Hsu, 2021, Frontiers in Immunology.

Peroxisome proliferator-activated receptor-γ as the gatekeeper of tight junction in Clostridioides difficile infection

Y. Tsai, P. Tsai, W. Ko, 2022, Frontiers in Microbiology.

Risk Factors and Clinical Impact of Carbapenem-Resistant Enterobacterales Coinfections Among Hospitalized Patients with Clostridioides difficile Infection

P. Tsai, W. Ko, Ching-Chi Lee, 2022, Infection and drug resistance.

Clostridioides difficile infection in patients with hematological malignancy: A multicenter study in Taiwan.

P. Tsai, W. Ko, P. Hsueh, 2021, Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi.

Risk factors of Clostridium difficile-associated diarrhea in hospitalized adults: Vary by hospitalized duration.

P. Tsai, W. Ko, Hsiu-Chuan Liu, 2019, Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi.

Fecal microbiota transplantation for Clostridium difficile infection in Taiwan: Establishment and implementation.

W. Ko, Y. Hung, Tien-Ching Lin, 2019, Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi.

Perceptions of Clostridium difficile infections among infection control professionals in Taiwan.

P. Tsai, W. Ko, I. Huang, 2017, Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi.

Clostridium difficile Infections in Medical Intensive Care Units of a Medical Center in Southern Taiwan: Variable Seasonality and Disease Severity

P. Tsai, W. Ko, Jen-Chieh Lee, 2016, PloS one.

Effect of Doxycycline in Decreasing the Severity of Clostridioides difficile Infection in Mice

P. Tsai, W. Ko, Chih-Yu Hsu, 2022, Antibiotics.

Vancomycin-resistant Clostridium innocuum bacteremia following oral vancomycin for Clostridium difficile infection.

P. Tsai, W. Ko, Po-Lin Chen, 2014, Anaerobe.

Antimicrobial susceptibility of clinical Enterobacteriaceae isolates at the emergency department in a regional hospital: A threat of extended spectrum beta-lactamase-producers among nursing home residents.

W. Ko, Chia-Wen Li, Ming-Chi Li, 2015, Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi.

Comparing the therapeutic efficacies of third-generation cephalosporins and broader-spectrum β-lactams as appropriate empirical therapy in adults with community-onset monomicrobial Enterobacteriaceae bacteraemia: a propensity score matched analysis.

W. Ko, Ching-Chi Lee, Y. Hung, 2017, International journal of antimicrobial agents.

Propensity score-matched analysis comparing the therapeutic efficacies of cefazolin and extended-spectrum cephalosporins as appropriate empirical therapy in adults with community-onset Escherichia coli, Klebsiella spp. and Proteus mirabilis bacteraemia.

W. Ko, N. Lee, Ching-Chi Lee, 2016, International journal of antimicrobial agents.

Clinical Benefit of Appropriate Empirical Fluoroquinolone Therapy for Adults with Community-Onset Bacteremia in Comparison with Third-Generation-Cephalosporin Therapy

W. Ko, Ching-Chi Lee, Jiun-Ling Wang, 2016, Antimicrobial Agents and Chemotherapy.

Clostridium butyricum therapy for mild-moderate Clostridioides difficile infection and the impact of diabetes mellitus

P. Tsai, W. Ko, I. Huang, 2021, Bioscience of microbiota, food and health.

Role of cytokine changes in clozapine‐induced fever: A cohort prospective study

K. Chen, P. Chen, I. Lee, 2017, Psychiatry and clinical neurosciences.

Corrigendum: The ATP-P2X7 Signaling Axis Is an Essential Sentinel for Intracellular Clostridium difficile Pathogen-Induced Inflammasome Activation

Y. Tsai, P. Tsai, W. Ko, 2019, Front. Cell. Infect. Microbiol..

Application of Microbiome Management in Therapy for Clostridioides difficile Infections: From Fecal Microbiota Transplantation to Probiotics to Microbiota-Preserving Antimicrobial Agents

P. Tsai, W. Ko, Ching-Chi Lee, 2021, Pathogens.

Risk of non-typhoidal Salmonella vascular infections is increased with degree of atherosclerosis and inflammation: A multicenter study in southern Taiwan.

W. Ko, N. Lee, Chia-Wen Li, 2021, Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi.

Clostridioides difficile infection in patients with hematological malignancy: A multicenter study in Taiwan

P. Tsai, W. Ko, P. Hsueh, 2021, Journal of Microbiology, Immunology and Infection.

Phage transcriptional regulator X (PtrX)-mediated augmentation of toxin production and virulence in Clostridioides difficile strain R20291

P. Tsai, Jenn-Wei Chen, W. Ko, 2023, bioRxiv.

Predictive models for short-term mortality and length of hospital stay among adults with community-onset bacteraemia before and during the COVID-19 pandemic: application of early data dynamics

Ching-Chi Lee, Y. Hung, Chih-Chia Hsieh, 2023, BMC Infectious Diseases.

Enhancement of NETosis by ACE2-cross-reactive anti-SARS-CoV-2 RBD antibodies in patients with COVID-19

T. Yeh, Y. Hung, Chiao-Hsuan Chao, 2024, Journal of biomedical science.

Prompt antimicrobial therapy and source control on survival and defervescence of adults with bacteraemia in the emergency department: the faster, the better

Po-Lin Chen, Ching-Chi Lee, Y. Hung, 2024, Critical care.

Clinical impact of Clostridium difficile colonization.

P. Tsai, W. Ko, Jen-Chieh Lee, 2015, Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi.